Our Transactions
Leadership across the largest and most complex situations
Lead Financial Advisor
on its pending €8.0 billion
acquisition of
from Vodafone Group
2024
Exclusive Financial Advisor
on its pending ~$2.3 billion
acquisition of
2024
Independent Financial Advisor
on its pending acquisition of three fill-finish sites for an upfront payment of $11 billion from Novo Holdings following its $16.5 billion acquisition of Catalent
2024
Exclusive Financial Advisor
on its pending ~$35 billion
acquisition of
2024
Exclusive Financial Advisor
on its pending ~$12.6 billion
sale to
2024
Lead Financial Advisor
on its pending $11.5 billion
all-stock merger with
2024
Lead Financial Advisor
on its pending ~$13.4 billion
sale to
2023
Financial Advisor
on its pending ~$14.9 billion
sale to
2023
Financial Advisor
on its pending $60 billion
all-stock acquisition of
2023
Financial Advisor
on its up to $5.8 billion
acquisition of
2023
Financial Advisor
on its pending ~$20 billion
merger with
2023
Lead Left Bookrunner
$300 million
Follow-on Offering
2023
Exclusive Financial Advisor
on its chapter 11 restructuring of ~$1.9 billion of debt and $125 million DIP ABL financing
2023
Active Bookrunner
$1.1 billion IPO & $1.6 billion
Follow-on Offering
2023
Exclusive Financial Advisor
on its pre-packaged chapter 11 restructuring of ~$3.6 billion of debt and preferred equity
2023
Lead Financial Advisor
on its ~$36 billion
spin-off of
2021
Anouncement Date1
Status
Transaction
Value (M)
December 14, 2020
Closed
Acted as a Joint Bookrunner on the follow-on offering for TG Therapeutics
$316
December 12, 2020
Closed
Advised AstraZeneca on its acquisition of Alexion
~$39,000
December 10, 2020
Closed
Acted as the Sole Bookrunner on the CAPSTM initial public offering for Periphas Capital Partnering Corporation
$414
December 10, 2020
Closed
Acted as a Joint Bookrunner on the initial public offering for 4D Molecular Therapeutics
~$222
December 9, 2020
Closed
Advised MTS Systems on its sale to Amphenol
~$1,700
December 8, 2020
Closed
Acted as an Active Bookrunner and Global Coordinator on the follow-on offering for Volaris
$173
December 8, 2020
Closed
Acted as an Active Bookrunner on the follow-on offering for Atara Biotherapeutics
$175
December 7, 2020
Closed
Advised Connells Limited and Skipton Building Society on their cash offer for Countrywide plc
£223
December 7, 2020
Closed
Advised Wellington Risk Holdings on its sale to Truist Financial Corporation from Aquiline Capital
N/A
December 3, 2020
Closed
Acted as a Joint Bookrunner on the follow-on offering and convertible notes offering for Shift4 Payments
~$1,201
1Announcement date for M&A transactions represents the date publicly announced; announcement date for restructurings represents the date publicly announced or filed; announcement date for capital markets transactions represents the pricing date.